Genetic idiotypic and tumor cell-based vaccine strategies for indolent non Hodgkin’s lymphoma
/in International Publications, Malignant Lymphoma /von 2005-10-01 / Curr Gene Ther 2005 Oct;5(5):511-21The immunotherapy of prostate and bladder cancer
/in International Publications, Urothelial Carcinoma /von 2005-10-01 / BJU Int. 2005 Oct;96(5):728-35Synergistic interaction of hyperthermia and Gemcitabine in lung cancer
/in International Publications, NSCLC /von 2005-10-01 / Cancer Biol. Ther. 2005 Oct;4(10):1144-53Dendritic cells pulsed with hsp70-peptide complexes derived from human hepatocellular carcinoma induce specific anti-tumor immune responses
/in Hepatocellular Carcinoma, International Publications /von 2005-09-28 / World J. Gastroenterol. 2005 Sep;11(36):5614-20Vaccination of melanoma patients using dendritic cells loaded with an allogeneic tumor cell lysate
/in Dendritic Cells, International Publications, Malignant Melanoma /von 2005-09-27 / Cancer Immunol Immunother 2006 Jul;55(7):819-29B cell tumor vaccine enhanced by covalent attachment of immunoglobulin to surface proteins on dendritic cells
/in International Publications, Malignant Lymphoma /von 2005-09-26 / Clin. Immunol. 2006 Jan;118(1):66-76Allogeneic dendritic cells pulsed with tumor lysates or apoptotic bodies as immunotherapy for patients with early-stage B-cell chronic lymphocytic leukemia
/in Chronic Leukemia, Dendritic Cells, International Publications /von 2005-09-01 / Leukemia 2005 Sep;19(9):1621-7[Current status of hyperthermia for therapy of brain tumor]
/in Glioblastoma, International Publications /von 2005-09-01 / Nippon Rinsho 2005 Sep;63 Suppl 9:483-9Immune-related effects of local hyperthermia in patients with primary liver cancer
/in Hepatocellular Carcinoma, International Publications /von 2005-09-01 / Hepatogastroenterology 2005 Sep-Oct;52(65):1502-6IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de